Owens DK - Search Results

1

Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.

Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. Rupnow MF, et al. Among authors: owens dk. J Infect Dis. 2009 Oct 15;200(8):1311-7. doi: 10.1086/605845. J Infect Dis. 2009. PMID: 19751153

2

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.

Parsonnet J, Harris RA, Hack HM, Owens DK. Parsonnet J, et al. Among authors: owens dk. Lancet. 1996 Jul 20;348(9021):150-4. doi: 10.1016/s0140-6736(96)01501-2. Lancet. 1996. PMID: 8684154 Free article.

3

Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?

Harris RA, Owens DK, Witherell H, Parsonnet J. Harris RA, et al. Among authors: owens dk. Helicobacter. 1999 Jun;4(2):69-76. doi: 10.1046/j.1523-5378.1999.98057.x. Helicobacter. 1999. PMID: 10382118

4

Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.

Rupnow MF, Owens DK, Shachter R, Parsonnet J. Rupnow MF, et al. Among authors: owens dk. Helicobacter. 1999 Dec;4(4):272-80. doi: 10.1046/j.1523-5378.1999.99311.x. Helicobacter. 1999. PMID: 10597398

5

A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States.

Rupnow MF, Shachter RD, Owens DK, Parsonnet J. Rupnow MF, et al. Among authors: owens dk. Emerg Infect Dis. 2000 May-Jun;6(3):228-37. doi: 10.3201/eid0603.000302. Emerg Infect Dis. 2000. PMID: 10827112 Free PMC article.

6

Quantifying the population impact of a prophylactic Helicobacter pylori vaccine.

Rupnow MF, Shachter RD, Owens DK, Parsonnet J. Rupnow MF, et al. Among authors: owens dk. Vaccine. 2001 Dec 12;20(5-6):879-85. doi: 10.1016/s0264-410x(01)00401-7. Vaccine. 2001. PMID: 11738753

7

Should we treat H. pylori infection to prevent gastric cancer?

Parsonnet J, Harris RA, Hack HM, Owens DK. Parsonnet J, et al. Among authors: owens dk. Gastroenterology. 1997 Mar;112(3):1044-5. doi: 10.1053/gast.1997.v112.agast971044. Gastroenterology. 1997. PMID: 9041272 Free article. No abstract available.

8

Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics.

Owens DK, Edwards DM, Shachter RD. Owens DK, et al. AIDS. 1998 Jun 18;12(9):1057-66. AIDS. 1998. PMID: 9662203

9

Cost-effectiveness of a potential vaccine for Coccidioides immitis.

Barnato AE, Sanders GD, Owens DK. Barnato AE, et al. Among authors: owens dk. Emerg Infect Dis. 2001 Sep-Oct;7(5):797-806. doi: 10.3201/eid0705.010505. Emerg Infect Dis. 2001. PMID: 11747691 Free PMC article.

10

Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States.

Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK. Perlroth DJ, et al. Among authors: owens dk. Clin Infect Dis. 2010 Jan 15;50(2):165-74. doi: 10.1086/649867. Clin Infect Dis. 2010. PMID: 20021259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page